Provided by Tiger Trade Technology Pte. Ltd.

HBM HOLDINGS-B

14.190
-0.250-1.73%
Volume:8.78M
Turnover:125.24M
Market Cap:12.33B
PE:129
High:14.740
Open:14.440
Low:13.980
Close:14.440
52wk High:17.880
52wk Low:9.460
Shares:869.00M
HK Float Shares:869.00M
Volume Ratio:0.52
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.110
ROE:23.97%
ROA:10.88%
PB:3.76
PE(LYR):129.00
PS:8.78

Loading ...

Company Profile

Company Name:
HBM HOLDINGS-B
Exchange:
SEHK
Establishment Date:
2016
Employees:
327
Office Location:
Building A3,Suite 202,218 Xinghu Street,Suzhou Industrial Park,Suzhou,Jiangsu Province,China
Website:
- -
Zip Code:
215123
Fax:
- -
Introduction:
Hbm Holdings Ltd is an investment holding company primarily engaged in the business of developing innovative therapeutics in the fields of immuno-oncology and immunology diseases. The Company’s products primarily include BATOCLIMAB (HBM9161), HBM9378, HBM7020, TCE Program, PORUSTOBART (HBM4003), HBM7022 and others. The products are primarily used to treat generalized myasthenia gravis (gMG), chronic obstructive pulmonary disease (COPD), asthma, autoimmune diseases, melanoma, colorectal carcinoma (CRC) and solid tumors. The Company provides next-generation antibody and biotherapeutic solutions through proprietary antibody technology platforms including Harbour Mice, HBICE, HBICA and single B cell cloning platform.

Directors

Name
Position
WANG Jin Song
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
CHEN You Chen
Executive Director
LIU Yi
Executive Director
Robert Irwin Kamen
Independent Director,Member of the Nomination Committee
Xiaoping Ye
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
Albert R.Collinson
Independent Director,Chairman of the Remuneration and Assessment Committee,Audit Committee Member
CHEN Wei Wei
Independent Director,Member of the Nomination Committee,Audit Committee Chairman

Shareholders

Name
Position
WANG Jin Song
CEO
TAO Xiao Lu
Vice General Manager,Other Senior Executives
CHEN You Chen
CFO
LV Ying Yi
Corporate Secretary
LIU Yi
Corporate Secretary
RONG Yi Ping
Chief Science Officer